Qian Tong

2.7k total citations · 3 hit papers
76 papers, 2.0k citations indexed

About

Qian Tong is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Qian Tong has authored 76 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Cardiology and Cardiovascular Medicine and 16 papers in Surgery. Recurrent topics in Qian Tong's work include Cardiac Imaging and Diagnostics (9 papers), Acute Myocardial Infarction Research (7 papers) and Berberine and alkaloids research (6 papers). Qian Tong is often cited by papers focused on Cardiac Imaging and Diagnostics (9 papers), Acute Myocardial Infarction Research (7 papers) and Berberine and alkaloids research (6 papers). Qian Tong collaborates with scholars based in China, United States and Belgium. Qian Tong's co-authors include Yang Zheng, Lu Cai, Zhenxiong Zhao, Xianfeng Zhang, Yuan Lin, Jian‐Dong Jiang, Jian Sun, Yi Tan, Xiang Wang and Quanwei Wang and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Qian Tong

65 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways

2021 370 citations Quanwei Wang, Qian Tong et al. Acta Pharmaceutica Sinica B profile →
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota

2021 240 citations Yan Wang, Qian Tong et al. Signal Transduction and Targeted Therapy profile →
Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota

2022 120 citations Shurong Ma, Qian Tong et al. Signal Transduction and Targeted Therapy profile →

Peers

Countries citing papers authored by Qian Tong

Since Specialization

Citations

This map shows the geographic impact of Qian Tong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qian Tong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qian Tong more than expected).

Fields of papers citing papers by Qian Tong

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qian Tong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qian Tong. The network helps show where Qian Tong may publish in the future.

Co-authorship network of co-authors of Qian Tong

This figure shows the co-authorship network connecting the top 25 collaborators of Qian Tong. A scholar is included among the top collaborators of Qian Tong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qian Tong. Qian Tong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Clinical predictive model of new-onset atrial fibrillation in patients with acute myocardial infarction after percutaneous coronary intervention 2025 ·Scientific Reports ·Xiaodan Wu, (unknown), Quanwei Wang, Xinyu Yang, Jingyue Wang, (unknown), Qian Tong	2
2	Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis 2025 ·JACC: Cardiovascular Interventions ·Haiwei Liu, Yi Li, Guosheng Fu, (unknown), Shao‐Liang Chen, (unknown), Bin Liu, Chunguang Qiu, Likun Ma, (unknown), Hui Li, Qian Tong, Ben He, Zening Jin, (unknown), Haitao Yuan, Miaohan Qiu, Ruiyan Zhang, (unknown)	4
3	Bacteroides fragilis-derived succinic acid promotes the degradation of uric acid by inhibiting hepatic AMPD2: Insight into how plant-based berberine ameliorates hyperuricemia 2025 ·Acta Pharmaceutica Sinica B ·Li‐Bin Pan, Ru Feng, (unknown), Hang Yu, Qian Tong, Xinyu Yang, (unknown), (unknown), (unknown), Zhengwei Zhang, Jie Fu, Haojian Zhang, (unknown), Zhao Zhai, Jingyue Wang, (unknown), (unknown), Hui Xiang, Jian‐Dong Jiang, (unknown)	1
4	Temperature-, pressure-dependent and photo-induced chiral enantiomeric spin crossover Fe(II) complexes 2025 ·Journal of Molecular Structure ·Liang Han, (unknown), Shan Zhang, Kuang–Chao Fan, (unknown), Qian Tong, Zhen Zhou, Lu Yang, Daopeng Zhang	0
5	Cuscuta chinensis Lam. Flavonoids (CCLF) alleviate the symptoms of sepsis-associated encephalopathy via PI3K/Nrf2 pathway 2024 ·Behavioural Brain Research ·(unknown), Liping Sheng, Qian Tong	2
6	Objective-assisted probabilistic strength learning particle swarm optimization for multi-agent cooperative task allocation 2024 ·Scientia Sinica Technologica ·Qian Tong, Jianyu Li, Xiaofang Liu, Zhi‐Hui Zhan, (unknown)	0
7	Clinical significance and risk factors of nonalcoholic fatty liver diseases after pancreaticoduodenectomy: a Retrospective Cohort Study 2024 ·HPB ·Kan Huang, (unknown), Qian Tong, Xiangzhi Bai, (unknown)	0
8	Anxiety, depression and sleep problems in PCI patients: a cross-lag panel analysis 2024 ·Current Psychology ·Xinmeng Guo, Zeying Qin, (unknown), (unknown), Junsong Fei, Songli Mei, Qian Tong	2
9	Smartphone-based gamification intervention to increase physical activity participation among patients with coronary heart disease: A randomized controlled trial 2023 ·Journal of Telemedicine and Telecare ·Linqi Xu, Qian Tong, Xin Zhang, (unknown), (unknown), Tianyue Yu, Maarten Falter, Martijn Scherrenberg, Toshiki Kaihara, (unknown), Hanne Kindermans, Paul Dendale, Feng Li	10
10	Research Progress of Skeletal Muscle Injury Repair and Treatment Strategies 2023 ·Qian Tong, (unknown), (unknown), Zhen Ruan, Panpan Guo, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
11	Berberine treats atherosclerosis via a vitamine-like effect down-regulating Choline-TMA-TMAO production pathway in gut microbiota breakdown → 2022 ·Signal Transduction and Targeted Therapy ·Shurong Ma, Qian Tong, Yuan Lin, Li‐Bin Pan, Jie Fu, Ran Peng, Xianfeng Zhang, Zhenxiong Zhao, (unknown), Jinbo Yu, Lin Cong, Pei Han, Zhengwei Zhang, Hang Yu, Yan Wang, Jian‐Dong Jiang	120
12	Biolimus-Coated Balloon in Small-Vessel Coronary Artery Disease 2022 ·JACC: Cardiovascular Interventions ·Kai Xu, Guosheng Fu, Qian Tong, Bin Liu, Xuebin Han, (unknown), Genshan Ma, Qing Yang, Hui Li, Yujie Zhou, (unknown), Yi Li, Yaling Han	24
13	Mobile health-based gamification intervention to increase physical activity participation among patients with coronary heart disease: study protocol of a randomised controlled trial 2022 ·BMJ Open ·Linqi Xu, Jinwei Li, (unknown), (unknown), (unknown), (unknown), Tianyue Yu, (unknown), Qian Tong, Feng Li	11
14	Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota breakdown → 2021 ·Signal Transduction and Targeted Therapy ·Yan Wang, Qian Tong, Shurong Ma, Zhenxiong Zhao, Li‐Bin Pan, Lin Cong, Pei Han, Ran Peng, Hang Yu, Yuan Lin, Tianle Gao, Jia‐Wen Shou, Xiaoyang Li, Xianfeng Zhang, Zhengwei Zhang, Jie Fu, Bao‐Ying Wen, Jinbo Yu, Xuetao Cao, Jian‐Dong Jiang	240
15	Single Nucleotide Polymorphisms of Porcine lncMGPF Regulate Meat Production Traits by Affecting RNA Stability 2021 ·Frontiers in Cell and Developmental Biology ·Wei Lv, (unknown), (unknown), Qian Tong, (unknown), Jianan Li, (unknown), Bo Zuo	4
16	Discharge Hemoglobin Association with Long-Term Outcomes of ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention 2020 ·Cardiovascular Therapeutics ·(unknown), Xinying Zhang, (unknown), Yang Zheng, Zhiguo Zhang, Qian Tong, (unknown)	4
17	Substrate metabolism regulated by Sestrin2–mTORC1 alleviates pressure overload-induced cardiac hypertrophy in aged heart 2020 ·Redox Biology ·Nanhu Quan, Xuan Li, Jingwen Zhang, Ying Han, Weiju Sun, Di Ren, Qian Tong, Ji Li	23
18	Traditional Chinese Medicine Tanreqing Inhibits Quorum Sensing Systems in Pseudomonas aeruginosa 2020 ·Frontiers in Microbiology ·Weifeng Yang, Qing Wei, Qian Tong, (unknown), (unknown), (unknown), (unknown), Pierre Cornélis, Yi Wang	23
19	Intravascular treatment of coarctation of the aorta coexisting with patent ductus arteriosus and aneurysm 2019 ·European Heart Journal ·Qian Tong, Chunyu Zhang, Xiang Qiu, (unknown)	1
20	Novel Curcumin C66 That Protects Diabetes‐Induced Aortic Damage Was Associated with Suppressing JNK2 and Upregulating Nrf2 Expression and Function 2018 ·Oxidative Medicine and Cellular Longevity ·Cheng Li, Xiao Miao, Shudong Wang, (unknown), (unknown), Jian Sun, Quan Liu, Qian Tong, Yonggang Wang	19

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact